212 related articles for article (PubMed ID: 3080463)
21. Effect of human growth hormone therapy on penile and testicular size in boys with isolated growth hormone deficiency: first year of treatment.
Laron Z; Mimouni F; Pertzelan A
Isr J Med Sci; 1983 Apr; 19(4):338-44. PubMed ID: 6406387
[TBL] [Abstract][Full Text] [Related]
22. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
23. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
Sulmont V; Brauner R; Fontoura M; Rappaport R
Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
[TBL] [Abstract][Full Text] [Related]
24. Human growth hormone (hGH) stimulation tests: the sequential exercise and L-dopa procedure.
Liberman B; Cesar FP; Wajchenberg BL
Clin Endocrinol (Oxf); 1979 Jun; 10(6):649-54. PubMed ID: 476987
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
26. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.
Job JC; Chaussain JL; Garnier P; Rolland A; Joab N
Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186
[TBL] [Abstract][Full Text] [Related]
27. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
28. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
[TBL] [Abstract][Full Text] [Related]
30. Management of the short stature due to pubertal delay in boys.
Adan L; Souberbielle JC; Brauner R
J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
[TBL] [Abstract][Full Text] [Related]
31. The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males.
Link K; Blizzard RM; Evans WS; Kaiser DL; Parker MW; Rogol AD
J Clin Endocrinol Metab; 1986 Jan; 62(1):159-64. PubMed ID: 3940264
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
Blethen SL; Daughaday WH; Weldon VV
J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
[TBL] [Abstract][Full Text] [Related]
33. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
[TBL] [Abstract][Full Text] [Related]
34. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
Marini JC; Bordenick S; Heavner G; Rose S; Hintz R; Rosenfeld R; Chrousos GP
J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
[TBL] [Abstract][Full Text] [Related]
35. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
[TBL] [Abstract][Full Text] [Related]
36. Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy.
Wu RH; St Louis Y; DiMartino-Nardi J; Wesoly S; Sobel EH; Sherman B; Saenger P
J Clin Endocrinol Metab; 1990 Jun; 70(6):1612-5. PubMed ID: 2347896
[TBL] [Abstract][Full Text] [Related]
37. Propranolol-augmented, exercise-induced human growth hormone release.
Maclaren NK; Taylor GE; Raiti S
Pediatrics; 1975 Nov; 56(5):804-7. PubMed ID: 1196739
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone therapy in short children without classical growth hormone deficiency.
Bierich JR
J Endocrinol Invest; 1989; 12(8 Suppl 3):25-33. PubMed ID: 2681346
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal urinary growth hormone excretion as a criterion for growth hormone deficiency.
Fortes ES; Chacra AR; Kunii HS; Vieira JG; Russo EM
Braz J Med Biol Res; 1995 Apr; 28(4):433-8. PubMed ID: 8520540
[TBL] [Abstract][Full Text] [Related]
40. Lack of seasonal influence on growth hormone therapy.
Kollipara S; Connors MH
Growth; 1985; 49(3):341-5. PubMed ID: 4085901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
